Sirmali Mehmet, Uz Efkan, Sirmali Rana, Kilbaş Aynur, Yilmaz H Ramazan, Altuntaş Irfan, Naziroğlu Mustafa, Delibaş Namik, Vural Hüseyin
Department of Thoracic Surgery, Süleyman Demirel University Medical School, Isparta, Turkey.
Biol Trace Elem Res. 2007 Jul;118(1):43-52. doi: 10.1007/s12011-007-0010-3.
The aim of this study was to investigate the protective effects of erdosteine and vitamins C and E (VCE) on the lungs after performing hind limb ischemia-reperfusion (I/R) by assessing oxidative stress, plasma copper (Cu), and zinc (Zn) analysis. The animals were divided randomly into four groups as nine rats each as follows: control, I/R, I/R plus erdosteine, and I/R plus VCE combination. I/R period for 60 min was performed on the both hind limbs of all the rats in the groups of I/R, erdosteine with I/R, VCE with I/R allowing 120 min of reperfusion. The animals received orally erdosteine one time in a day and 3 days before I/R in the erdosteine group. In the VCE group, the animals VCE combination received one time in a day and 3 days before I/R, although placebo was given to control and I/R group animals. Lung lipid peroxidation (malondialdehyde [MDA]) level, superoxide dismutase (SOD), and catalase activities were increased, although lung glutathione (GSH) and plasma Zn levels decreased in I/R group in lung tissue compared with the control group. Serum MDA level, creatine kinase, and lactate dehydrogenase activities were increased in I/R group compared with the control. Lung MDA and plasma Zn levels and lung SOD activity were decreased by erdosteine administration, whereas lung GSH levels after I/R increased. The plasma Zn levels and lung SOD activity were decreased by VCE administration, although the plasma Cu and lung GSH levels increased after I/R. In conclusion, erdosteine has an antioxidant role on the values in the rat model, and it has more protective affect than in VCE in attenuating I/R-induced lung injury in rats.
本研究旨在通过评估氧化应激、血浆铜(Cu)和锌(Zn)分析,探讨厄多司坦及维生素C和E(VCE)对后肢缺血再灌注(I/R)后肺部的保护作用。将动物随机分为四组,每组9只大鼠,分别为:对照组、I/R组、I/R加厄多司坦组和I/R加VCE联合组。对I/R组、厄多司坦与I/R组、VCE与I/R组的所有大鼠双后肢进行60分钟的I/R,再灌注120分钟。厄多司坦组动物在I/R前3天每天口服一次厄多司坦。在VCE组,动物在I/R前3天每天接受一次VCE联合用药,而对照组和I/R组动物给予安慰剂。与对照组相比,I/R组肺组织中肺脂质过氧化(丙二醛[MDA])水平、超氧化物歧化酶(SOD)和过氧化氢酶活性增加,而肺谷胱甘肽(GSH)和血浆Zn水平降低。与对照组相比,I/R组血清MDA水平、肌酸激酶和乳酸脱氢酶活性增加。给予厄多司坦可降低肺MDA和血浆Zn水平以及肺SOD活性,而I/R后肺GSH水平升高。给予VCE可降低血浆Zn水平和肺SOD活性,而I/R后血浆Cu和肺GSH水平升高。总之,厄多司坦在大鼠模型中具有抗氧化作用,在减轻大鼠I/R诱导的肺损伤方面,其保护作用比VCE更强。